Metronomic chemotherapy and immunotherapy in cancer treatment-Reference-Cited by-同舟云学术

Metronomic chemotherapy and immunotherapy in cancer treatment

Published:2017-08 Issue: Volume:400 Page:282-292
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Chen Yu-Li,Chang Ming-Cheng,Cheng Wen-Fang

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference128 articles.

1. The principles of cancer treatment by chemotherapy;Caley;Surgery,2012

2. Metronomic scheduling: the future of chemotherapy?;Gasparini;Lancet Oncol.,2001

3. Mercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fiction;Schmiegelow;J. Pediatr. Hematol. Oncol.,2014

4. Implications of biochemical, cytokinetic, pharmacologic, and toxicologic relationships in the design of optimal therapeutic schedules;Skipper;Cancer Chemother. Rep.,1970

5. Dose: a critical factor in cancer chemotherapy;Frei;Am. J. Med.,1980

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study;Oral Oncology;2024-11

2. Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study;Oral Oncology;2024-09

3. A transformable and self-oxygenated smart probe for enhanced tumor sonodynamic therapy;Acta Biomaterialia;2024-08

4. Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology;Frontiers in Veterinary Science;2024-06-06

5. Cross-Talks between Raf Kinase Inhibitor Protein and Programmed Cell Death Ligand 1 Expressions in Cancer: Role in Immune Evasion and Therapeutic Implications;Cells;2024-05-17